BeOne Medicines

04/27/2026

“As a patient, you don’t always know what to ask – that’s why having an advocate matters.”

In this video, Richard reflects on the role others played throughout his journey with esophageal cancer, from caregivers and loved ones to the wider care team supporting him along the way.

A story like this highlights why progress in cancer care – and ongoing support for those navigating it – is so important.

Learn more about Richard’s story here: https://beonemedicines.com/stories/living-with-cancer-richards-story/

04/20/2026

We’re proud to recognize BeOne Medicines as a valued partner and sponsor of our Global Impact Celebration.

Through our partnership, BeOne Medicines, together with the BeOne Care Foundation, has helped support 293 people living with Chronic Lymphocytic Leukemia (CLL) across Armenia, Nepal, and Ethiopia access transformational medicines.

This work represents more than numbers. It reflects care reaching people, families finding hope, and health systems growing stronger through collaboration.

Thank you for helping ensure that geography does not determine a person’s chance to survive cancer. 🙏🏽

https://buff.ly/KGIL27y

04/17/2026

Today is WM World Awareness Day.

Join the IWMF and our Global Partners across 21 countries as we work together to raise awareness of .

We are united as a worldwide support network with one mission: ensuring that everyone affected by Waldenstrom macroglobulinemia—no matter where they live—has access to the guidance, care, and community they deserve.

We support, educate, and empower everyone affected while advancing the search for a cure.

We are stronger together.

Join the IWMF for all the latest updates in research, education, and support:
https://iwmf.com/join-the-iwmf/

04/14/2026

Putting patients first starts with how we innovate and operate.

At BeOne, our focus on advancing cancer care and improving access means we must operate responsibly and with sustainability in mind.

Explore our 2025 Responsible Business & Sustainability Report to learn more about our approach and progress to date:https://beonemedicines.com/wp-content/uploads/2026/04/BeOneMedicines_2025-SustainabilityReport_V3.3.pdf

04/09/2026

Esophageal cancer can sometimes go unnoticed until it has progressed.

Early detection can make a difference. Recognizing the signs and speaking with a healthcare professional if something doesn’t feel right may help.

At BeOne, we’re committed to supporting efforts that raise awareness and improve access to care for people affected by esophageal cancer.

03/30/2026

AI is already changing how blood cancer patients navigate their care. We shared with USA TODAY how BeOne is bringing patients and advocates to the table to shape AI tools that are accurate, trustworthy, and built around real-world needs of patients.

Read and learn more: https://www.usatoday.com/story/sponsor-story/beone-fph/2026/03/27/why-ai-cancer-care-tools-must-be-developed-with-patients-and-advocates/89070315007/


Mediaplanet

‏‏‎ ‎

03/24/2026

AI is changing how people living with blood cancer find information – but knowing how to use it safely matters.

More than 40 million people around the world now turn to AI tools for health information each day, often before speaking with their doctor.

We brought together patients, advocates and experts to better understand how AI is being used and how to make it safer and more helpful for the cancer community.

Based on these insights, we’ve created a guide to help you:
- Understand what AI can and can’t do
- Avoid common mistakes
- Use AI in a way that supports, not replaces, your care team

If you’re using AI or thinking about it, this is a helpful place to start.

Read more in Cancer Health: https://www.cancerhealth.com/article/ai-shaping-future-blood-cancer-care-patients-can-harness-safely

03/19/2026

Thank you, Cancer Support Community, for spotlighting this critical issue. For patients with blood cancers like chronic lymphocytic leukemia (CLL), step therapy policies imposed by insurers and PBMs can delay, deny, or disrupt access to the treatment their doctor prescribed when every moment counts.

In cancer care, time lost can mean life lost.

Across the country, insurers and pharmacy benefit managers are delaying or denying cancer treatment through step therapy and prior authorization. Patients are told to switch medicines or “fail first” on one treatment before accessing the therapy their doctor prescribed.

In oncology, treatment decisions are too often influenced by cost-driven policies instead of medical expertise. This new op-ed explores what these delays look like inside the clinic and why patients deserve better.

🗞️ Learn more: https://www.orlandosentinel.com/2026/03/08/commentary-when-insurers-cross-the-line-in-cancer-care-patients-pay-the-price/

03/17/2026

Meet Kristian Stubbs, our General Manager, Canada at BeOne.

Driven by a personal connection to cancer, he is committed to expanding access to our innovative cancer therapies to the people who need them.

Swipe to learn more.

03/11/2026

Impact is not only measured by what we achieve, but also how we show up for others.

As part of our commitment to creating a positive impact, the BeOne Care Foundation supports initiatives that eliminate barriers to accessible cancer care in underserved communities.

From funding critical programs to driving disease awareness, swipe to learn how we helped to make a difference in 2025 through our Access to Cancer Care grants.

02/28/2026

This we’re shining a light on the 300 million people worldwide living with a rare disease.

While each rare disease is unique, there are many shared challenges, including delayed or missed diagnoses, limited care options, research and data limitations, and barriers to access.

At BeOne, we’re committed to improving treatment options for those affected by rare diseases like Mantle Cell Lymphoma (MCL), a type of blood cancer.

Join us in raising awareness, sharing support, and standing with the rare disease community today.